首页> 外国专利> Dual specific Protein Union directed against Interleukin 1B (il-1beta) and / or Interleukin 17 (IL - 17)

Dual specific Protein Union directed against Interleukin 1B (il-1beta) and / or Interleukin 17 (IL - 17)

机译:针对白介素1B(il-1beta)和 /或白介素17(IL-17)的双重特异性蛋白质联盟

摘要

Multivalent binding proteins that bind to Multispecies manipulated and il-1b and / or il-17, together with Methods of Preparation and their use in the Prevention, diagnosis and / or treatment of a disease.Claim 1: a Binding Protein that comprises a First and a Second polypeptide Chain, each of which is independently vdu00b9 - (xu00b9) u2099 - vdu00b2 - C - X, whereVdu00b9 is a First variable domain is a domain variable vdu00b2; Second, C is a constant Domain; xu00b9 is a Connector with the condition not CH1; X is a FC region that is either present or absent; n is 0 OR 1,In Domains where vdu00b9 in said first and said Second polypeptide Chain forming a First Binding Site and the White vdu00b2 Functional Domains in the first and the second polypeptide Chain forming a Second White Functional binding site, and the binding protein. Ese the ability to join the il-1b and il-17, where(i) the variable domains that form a functional binding site for White il-1beta include: The COR 1 to 3 of SEQ ID no. 34 and the COR 1 to 3 of SEQ ID no. 35, the COR 1 to 3 of SEQ ID no. 32 and the COR 1 to 3 of the SEQ ID no. 33, the cor 1 to 3 of SEQ ID no. 36 and the COR 1 to 3 of the seq ID no. 37, the COR 1 to 3 of SEQ ID no. 38 and the COR 1 to 3 of SEQ ID no. 39The Cor or 1 to 3 of SEQ ID no. 40 and the COR 1 to 3 of SEQ ID no. 41; and / or binding protein has the ability to bind to the IL - 1B with a KD value of maximum 10u207bu00b9u00b2 approximately 5.1 x m, u1d50u1d49u1d48u2071u1d48u1d52 u1d56u1d52u02b3 u02b3u1d49u02e2u1d52u207fu1d43u207fu1d9cu2071u1d43 u1d48u1d49 u1d56u02e1u1d43u02e2u1d50u00f3u207f u02e2 u1d58u1d56u1d49u02b3u1da0u2071u1d9cu2071u1d43u02e1, u1d52 u02e1u1d43 u1d9cu1d43u1d56u1d43u1d9cu2071u1d48u1d43u1d48 u1d56u1d43u02b3u1d43 u2071u207fu02b0u2071u1d47u2071u02b3 u02e1u1d43 ilu207bu00b9b with a value of approximately 500 nm of maximum lcu2085u2080 as measured in a Neutralization Assay of IL - 1BAnd / or (ii) the variable domains that form a functional binding site for white include the il-17 COR 1 to 3 of SEQ ID no. 44 and the COR 1 to 3 of SEQ ID no. 45; The COR 1 to 3 of SEQ ID no. 42 and the COR 1 to 3 The SEQ ID no. 43; or The COR 1 to 3 of SEQ ID no. 46 and the COR 1 to 3 l To SEQ ID no. 47; and / or binding protein has the ability to bind to the IL - 17 with a KD value of COmo maximum approximately 4.8 m x 10u207bu00b9u00b2, u1d50u1d49u1d48u2071u1d48u1d52 u1d56u1d52u02b3 u02b3u1d49u02e2u1d52u207fu1d43u207fu1d9cu2071u1d43 u1d48u1d49 u1d56u02e1u1d43u02e2u1d50u00f3u207f u02e2u1d58u1d56u1d49u02b3u1da0u2071u1d9cu2071u1d43u02e1, u1d52 u1d57u2071u1d49u207fu1d49 u02e1u1d43 u1d9cu1d43u1d56u1d43u1d9cu2071u1d48u1d43u1d48 u1d56u1d43u02b3u1d43 u2071u207fu02b0u2071u1d47u2071u02b3 u02e1u1d43 ilu207bu00b9u2077 u1d9cu1d52u207f u1d58u207f u1d5bu1d43u02e1u1d52u02b3 u1d48 u1d49 icu2085u2080 maximum of approximately 1.7 nm, measured in a test of Neutralization of il-17.
机译:与多物种结合的多价结合蛋白和il-1b和//或il-17结合在一起,以及制备方法及其在疾病的预防,诊断和/或治疗中的用途。权利要求1:一种结合蛋白,包括第一和第二多肽链,其各自独立地为vd u00b9-(x u00b9) u2099-vd u00b2-C-X,其中Vd u00b9是第一可变域是域变量vd u00b2;其次,C是一个常量域; x u00b9是条件不是CH1的连接器; X是存在或不存在的FC区域; n是0或1,在所述第一和所述第二多肽链中的vd u00b9形成第一结合位点而在所述第一和第二多肽链中的白vd u00b2功能域中形成第二白功能结合位点的域,以及结合蛋白。具有连接il-1b和il-17的能力,其中(i)形成White il-1beta的功能性结合位点的可变域包括:SEQ ID No.1的COR 1至3。 SEQ ID No.34和COR 1至3。 SEQ ID No.35的COR 1至3。 SEQ ID no.32和COR 1至3。 SEQ ID No.33的cor 1至3。 36和seq ID号为COR 1至3。在图37中,SEQ ID No.3的COR 1至3。 SEQ ID No.38和COR 1至3。 39 Cor或SEQ ID No.1至3 40和SEQ ID No.3的COR 1至3。 41;和/或结合蛋白具有以最大10 u207b u00b9 u00b2的KD值约5.1 xm, u1d50 u1d49 u1d48 u2071 u1d48 u1d52 u1d56 u1d52 u02b3 u02b3 u1d49 u02e2 u1d52 u207f u1d43 u207f u1d9c u2071 u1d43 u1d48 u1d49 u1d56 u02e1 u1d43 u02e2 u1d50 u00f3 u2 u1 u1d43 u1da0 u2071 u1d9c u2071 u1d43 u02e1, u1d52 u02e1 u1d43 u1d9c u1d43 u1d56 u1d43 u1d9c u2071 u1d48 u1d43 u1d48 u1d56 u1d48 u1d56 u1d56 u1d56 u1d56 u1d56 u1d56 u1d56 u1d56 u2071 u1d47 u2071 u02b3 u02e1 u1d43 il u207b u00b9b,在IL-1B和 /或(ii)可变域的中和测定中测得的最大lc u2085 u2080的值约为500 nm形成白色的功能性结合位点的SEQ ID No.1的il-17 COR 1至3。 SEQ ID No.44和COR 1至3。 45; SEQ ID no.1的COR 1至3。 SEQ ID No.42和COR 1至3。 43;或SEQ ID No.3的COR 1至3。 SEQ ID No.46和COR 1至3。 47;和/或结合蛋白具有结合IL-17的能力,其KD值的COmo最大值约为4.8 mx 10 u207b u00b9 u00b2, u1d50 u1d49 u1d48 u2071 u1d48 u1d52 u1d56 u1d52 u02b3 u02b3 u1d49 u02e2 u1d52 u207f u1d43 u207f u1d9c u2071 u1d43 u1d48 u1d49 u1d56 u02e1 u1d43 u02e2 u1d50 u1f43 u1 u1d43 u1da0 u2071 u1d9c u2071 u1d43 u02e1, u1d52 u1d57 u2071 u1d49 u207f u1d49 u02e1 u1d43 u1d9c u1d43 u1d56 u1d43 u1d9c u1d9c u1d9c u1d9c u1d9c u1d9c u1d43 u02b3 u1d43 u2071 u207f u02b0 u2071 u1d47 u2071 u02b3 u02e1 u1d43 il u207b u00b9 u2077 u1d9c u1d52 u207f u1d58 u1 u1d58 u1 u1d58 u1 u1d58 u1 u1d58在il-17中和测试中测得的最大值约为1.7 nm。

著录项

  • 公开/公告号AR095590A1

    专利类型

  • 公开/公告日2015-10-28

    原文格式PDF

  • 申请/专利权人 ABBVIE INC.;

    申请/专利号AR2014P101215

  • 申请日2014-03-17

  • 分类号C07K16/24;A61K39/395;A61K47/48;A61P37/06;C07K16/46;C12N5/10;C12N15/13;C12P21/08;G01N33/53;

  • 国家 AR

  • 入库时间 2022-08-21 15:16:27

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号